Literature DB >> 12953749

Prognostic factors in renal cell carcinoma.

James A Kontak1, Steven C Campbell.   

Abstract

Several well-established prognostic factors are now available for RCC and have proven utility for patient counseling and management. Consideration of these factors allows for a rational stratification of patients into clinical trials and facilitates the comparison of reports from diverse institutions. Tumor stage remains the most important prognostic factor for RCC, but compelling data have also been accumulated in support of various clinical signs and symptoms, tumor grade, size, histologic subtype, and DNA content and nuclear morphometry. Novel efforts to integrate these factors show great promise and are likely to incorporate molecular factors in the near future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12953749     DOI: 10.1016/s0094-0143(03)00020-x

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  18 in total

1.  Use of the University of California Los Angeles Integrated Staging System (UISS) to predict survival in localized renal cell carcinoma in an Asian population.

Authors:  Chi-Fai Ng; Siu-Ho Wan; Annie Wong; Fernand M M Lai; Pun Hui; Chi-Wai Cheng
Journal:  Int Urol Nephrol       Date:  2006-12-19       Impact factor: 2.370

2.  Co-existing sarcoidosis confounds the staging of bilateral renal cell carcinoma.

Authors:  Heather Willis; Marta Heilbrun; Christopher Dechet
Journal:  J Radiol Case Rep       Date:  2011-01-01

Review 3.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Unilateral renal cell carcinoma in a Labrador retriever.

Authors:  Fleur Bennett
Journal:  Can Vet J       Date:  2004-10       Impact factor: 1.008

5.  Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.

Authors:  Rebecca L O'Malley; Matthew H Hayn; Katherine A Brewer; Willie Underwood; Nicholas J Hellenthal; Hyung L Kim; Igor Sorokin; Thomas Schwaab
Journal:  World J Urol       Date:  2015-03-25       Impact factor: 4.226

6.  Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma.

Authors:  Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua
Journal:  Int Urol Nephrol       Date:  2008-08-05       Impact factor: 2.370

Review 7.  Epidemiology and staging of renal cell carcinoma.

Authors:  Carole A Ridge; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

8.  Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.

Authors:  Gu-Shun Lai; Jian-Ri Li; Shian-Shiang Wang; Chuan-Shu Chen; Chun-Kuang Yang; Sheng-Chun Hung; Chen-Li Cheng; Yen-Chuan Ou; Kun-Yuan Chiu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

9.  Clinicohistological characteristics of renal cell carcinoma in children: A multicentre study.

Authors:  Jeong Ho Kim; Seong Il Seo; Cheryn Song; Jinsoo Chung; Cheol Kwak; Sung-Hoo Hong
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

10.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.